He encontrado que alguna farmacia puede tener existencias limitadas de ciertos medicamentos, mientras que otras pueden tener casi cualquier formato que se le ocurra y el habitual de dosis habitualidad apareció. En resumen, siempre se contiene el almacén de corroborar. Al mismo tiempo que el producto que más que gustaba ha resultado no estaba disponible en stock otro distinto por las Buenas costumbres también debe buscarse jefe no asн parezca. Por eso es importante disponer de un Plan B para actuar cuandod ello no ocurra.
Ventaja de tomar un genérico en lugar de Asix
Un genérico es más barato que el nombre de marca
Uno de los mayores incentivos para someterse al Dónde comprar Lasix genérico en lugar de pagar la marca es que usted puede obtener un ahorrando importantes Lasix genérico. Por lo tanto, un Lasix genérico es en general mucho más barato que el homólogo de marca, así que una denominación genérica se hace posible para las personas que usan este medicamento con frecuencia. Un ejemplo: La compra de lurosemida en lugar de Lasix es una considerable ahorro para el presupuesto mensual de medicamentos.
Microsoft word - trustplus.formulary 2004.07.01 wcaduet.doc
BRAND GENERIC BRAND
ANTIHISTAMINE / DECONGESTANTS
Other Anti-Infectives. . . . . . . . . . . . . . . . . . . . . .
Trust Plus
Pharmacy Benefit Consultants
EXPECTORANT AND COUGH PRODUCTS---------
July 2004
Antifungal Agents. . . . . . . . . . . . . . . . . . . . . . . . . .
INTRODUCTION
Promethazine/Codeine or DM generics only
This condensed formulary is designed to serve as
Promethazine/Phenylephrine generics only
a reference guide and assist in the selection of
Promethazine/Phenylephrine/ generics only
cost-effective pharmaceutical products. The
formulary is not intended to be a substitute for
Triprolidine/Pseudoephedrine/ generics only
your clinical knowledge and judgment. In all
ANTIVIRALS ---------------------------------------------------
cases, the prescriber is expected to select
NASAL CORTICOSTEROIDS ----------------------------
appropriate drug therapy for the individual patient
Committee will regularly review the formulary to
ensure it meets the needs of both patients and
NASAL ANTIHISTAMINES --------------------------------
providers. Thank you in advance for your
OTHER NASAL AGENTS ---------------------------------
ANTI-INFECTIVE AGENTS (ORAL)
ANTIDIABETIC AGENTS
Presently, all drugs specifically indicated for the
ANTHELMINTICS --------------------------------------------
treatment of HIV and its opportunistic infections are
INSULINS ------------------------------------------------------
Rapid-Acting Insulins . . . . . . . . . . . . . . . . . . . . . . .
ANTIBIOTICS--------------------------------------------------
ANTINEOPLASTIC AND IMMUNOSUPPRESSIVE
Cephalosporins. . . . . . . . . . . . . . . . . . . . . . . . . . . .
All oral FDA-approved antineoplastic and
immunosuppressive agents are on Formulary.
Coverage is determined by the member’s Plan.
Intermediate-Acting Insulins . . . . . . . . . . . . . . . . .
AUTONOMIC & CENTRAL NERVOUS SYSTEM
Macrolides . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
ALZHEIMER’S AGENTS -----------------------------------
Erythromycin Ethylsuccinate generic/Eryped
ANALGESICS, NARCOTIC -------------------------------
Long-Acting Insulins . . . . . . . . . . . . . . . . . . . . . . . .
Penicillins . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
ORAL --------------------------------------------------------------
Quinolones . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Sulfonamides . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Tetracyclines . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
OTHER ANTIDIABETIC AGENTS ------------------------
BRAND GENERIC BRAND GENERIC BRAND
ANTI-ADRENERGIC BLOCKERS – CENTRALLY
ACTING -------------------------------------------------------------
Propoxyphene/APAP 325mg gen/Darvocet N-50
ANALGESICS, NONSTEROIDAL ANTI-
INFLAMMATORY ------------------------------------------
MIGRAINE AGENTS------------------------------------------
ANTI-ADRENERGIC BLOCKERS – PERIPHERALLY
ACTING-------------------------------------------------------------
ANTIARRHYTHMICS ------------------------------------------
OBSESSIVE COMPULSIVE DISORDER AGENTS---
PSYCHOTHERAPEUTIC AGENTS -----------------------
Antidepressants . . . . . . . . . . . . . . . . . . . . . . . . . . . .
ANALGESICS, SALICYLATES --------------------------
ANTICONVULSANTS -------------------------------------
ANTICOAGULANTS/ANTITHROMBOTICS ------------
ANTILIPEMICS ---------------------------------------------------
Antimanic Agent . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Antipsychotic Agents . . . . . . . . . . . . . . . . . . . . . . . .
ANTIPARKINSON AGENTS ------------------------------
CALCIUM CHANNEL BLOCKERS -------------------------
COMBINATION ANTIHYPERTENSIVES ------------------
CARDIOVASCULAR AGENTS
ANXIOLYTICS, SEDATIVES, AND HYPNOTICS
ALDOSTERONE ANTAGONISTS -------------------------
ANGIOTENSIN II ANTAGONISTS -------------------------
ANGIOTENSIN CONVERTING ENZYME INHIBITORS
DIURETICS -------------------------------------------------------
CEREBRAL STIMULANTS --------------------------------
ANTI-ADRENERGIC AGENTS – BETA-BLOCKERS --
Methylphenidate CD/ER/LA Metadate CD/ER/
DMARDS --------------------------------------------------------
VASODILATORS -------------------------------------------------
BRAND GENERIC BRAND GENERIC BRAND
ANTIBIOTICS -----------------------------------------------------
ANTISPASMODIC/ GI MOTILITY ----------------------------
CONTRACEPTIVES
ANTIVIRALS ------------------------------------------------------
MONOPHASIC --------------------------------------------------
FUNGICIDES ------------------------------------------------------
ANTIULCER -------------------------------------------------------
TOPICAL ANTI-INFLAMMATORY AGENTS -------------
Low Potency . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
BOWEL EVACUANTS ------------------------------------------
DIGESTANTS -----------------------------------------------------
Intermediate Potency . . . . . . . . . . . . . . . . . . . . . . . . .
OTHER GI PRODUCTS ----------------------------------------
BI-PHASIC ---------------------------------------------------------
High Potency . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
TRI-PHASIC -------------------------------------------------------
GOUT AGENTS
Highest Potency . . . . . . . . . . . . . . . . . . . . . . . . . . . .
HORMONES
OTHER DERMATOLOGICALS ------------------------------
PROGESTIN ONLY ----------------------------------------------
ANDROGENS ----------------------------------------------------
EMERGENCY CONTRACEPTION --------------------------
ANTIESTROGENS/ANTIANDROGENS -------------------
CONTRACEPTIVE DEVICES ---------------------------------
ESTROGENS --------------------------------------------------
CORTICOSTEROIDS
Methoxsalen Lotion/Capsule Oxsoralen/Ultra
Prednisolone Tablets/Liquid generics only
DIAGNOSTICS
DERMATOLOGICALS
ACNE ----------------------------------------------------------------
ESTROGEN AND ANDROGEN COMBINATIONS
GASTROINTESTINAL AGENTS
ESTROGEN AND PROGESTERONE
COMBINATIONS -----------------------------------------------
Sodium sulfacetamide/Sulfur generic/Plexion/TS
ANTIEMETIC/ ANTIVERTIGO --------------------------------
BRAND GENERIC BRAND GENERIC BRAND
ANTI-INFLAMMATORY AGENTS ---------------------------
SKELETAL MUSCLE RELAXANTS
FERTILITY REGULATORS -----------------------------------
BETA-BLOCKERS ----------------------------------------------
GROWTH HORMONE ------------------------------------------
THYROID AND ANTITHYROID AGENTS
PROGESTINS -----------------------------------------------------
VASOCONSTRICTORS ----------------------------------------
MISCELLANEOUS OPHTHALMIC AGENTS ------------
OSTEOPOROSIS AGENTS
SELECTIVE RECEPTOR MODULATORS ----------------
URINARY AGENTS
IMMUNOLOGIC AGENTS
Oxybutynin Transdermal/XL Oxytrol/Ditropan XL
VAGINAL PREPARATIONS
ANTI-INFECTIVE AND ANTI-INFLAMMATORY
COMBINATIONS -------------------------------------------------
IMPOTENCE AGENTS
RESPIRATORY/ASTHMA
OPHTHALMICS
ANTI-ASTHMATIC AGENTS ---------------------------------
MISCELLANEOUS AGENTS
Antileukotrienes . . . . . . . . . . . . . . . . . . . . . . . . . . . .
ANTI-ALLERGIC AGENTS ------------------------------------
Corticosteroids . . . . . . . . . . . . . . . . . . . . . . . . . . . .
ANTI-GLAUCOMA AGENTS----------------------------------
Sympathomimetics . . . . . . . . . . . . . . . . . . . . . . . . .
ANTI-INFECTIVE/ANTIVIRAL AGENTS -------------------
Xanthine Derivatives . . . . . . . . . . . . . . . . . . . . . . . .
OTHER RESPIRATORY/ASTHMA AGENTS ------------
ANTI-INFECTIVE AND ANTI-INFLAMMATORY
COMBINATIONS -------------------------------------------------
Administered on behalf of HealthTrans by: WellPoint Pharmacy Management
8407 Fallbrook Avenue / West Hills, CA 91304
WellPoint Pharmacy Management is a Registered Mark of
WellPoint Health Networks Inc. Services provided by Professional Claim Services Inc. doing business as WellPoint
Source: http://www.trustplus.net/files/TrustPlus.Formulary.pdf
Pain and pain relief in infants and children Some questions Background Newborn infants do feel and experience painprocedures commonly cause avoidance responses and other expressions of pain. demonstrated for a long time after the infant was subjected to a painful procedure without the benefit of analgesia. Background CNS nerve fibers for pain are myelinized already a
List of Hazardous Agents Requiring Reporting to IUPUI Office of Environmental Health and Safety Chemical Name CAS Number EHS Reporting Requirement Statement (MPTP) 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridineIrreversible parkisonism. Selegiline HCL antidote required1-(2-Chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosourea (Methyl-CCNU; 1,4-Butanediol dimethanesulfonate (Busulphan;Myler
A |
B |
C |
D |
E |
F |
G |
H |
I |
J |
K |
L |
M |
N |
O |
P |
Q |
R |
S |
T |
U |
V |
W |
X |
Y |
Z |
0-9 |